Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.

Quinn, G P; Vadaparampil, S T; Bower, B; Friedman, S; Keefe, D L

Quinn, G P; Vadaparampil, S T; Bower, B; Friedman, S; Keefe, D L.

Affiliation

Quinn GP; Moffitt Cancer Center and Research Institute, Division of Cancer Prevention and Control, Tampa, FL, USA. gwen.quinn@moffitt.org

Minerva Med ; 100(5): 371-83, 2009 Oct.

Article in En | MEDLINE | ID: mdl-19910890

Subject(s)

Breast Neoplasms/genetics; Decision Making/ethics; Genes, BRCA1; Genes, BRCA2; Heterozygote; Ovarian Neoplasms/genetics; Preimplantation Diagnosis/ethics; Breast Neoplasms/diagnosis; Female; Genetic Counseling; Genetic Markers/genetics; Genetic Predisposition to Disease; Genetic Testing; Humans; Mutation; Ovarian Neoplasms/diagnosis; Practice Guidelines as Topic; Prenatal Diagnosis/ethics; Reproductive Techniques, Assisted/ethics; Risk Assessment

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms / Genes, BRCA1 / Preimplantation Diagnosis / Genes, BRCA2 / Decision Making / Heterozygote Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Aspects: Ethics Limits: Female / Humans Language: En Journal: Minerva Med Year: 2009 Document type: Article

Search on Google

XML

PubMed Links